[S02DA03, antipyrine, The metabolism of Antipyrine can be increased when combined with Carbamazepine.]
[A14AA02, stanozolol, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Stanozolol.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be increased when combined with Carbamazepine.]
[B01AD01, streptokinase, The risk or severity of bleeding can be increased when Streptokinase is combined with Carbamazepine.]
[J01GA01, streptomycin, Streptomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA04, rabbit anti-human T-lymphocyte globulin, The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Carbamazepine.]
[L01AD04, streptozocin, The risk or severity of adverse effects can be increased when Streptozocin is combined with Carbamazepine.]
[L04AA27, fingolimod, The serum concentration of Fingolimod can be decreased when it is combined with Carbamazepine.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Carbamazepine.]
[A02BX02, sucralfate, Sucralfate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01CG01, sulbactam, Sulbactam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01EC02, sulfadiazine, The metabolism of Sulfadiazine can be increased when combined with Carbamazepine.]
[J01EC01, sulfamethoxazole, The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Carbamazepine.]
[M04AB02, sulfinpyrazone, The metabolism of Carbamazepine can be increased when combined with Sulfinpyrazone.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Sulpiride is combined with Carbamazepine.]
[N03AX03, sulthiame, Carbamazepine may increase the Change in thyroid function activities of Sulthiame.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01BB02, mercaptopurine, The serum concentration of Mercaptopurine can be decreased when it is combined with Carbamazepine.]
[N06DA01, tacrine, The metabolism of Tacrine can be increased when combined with Carbamazepine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Carbamazepine.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be increased when combined with Carbamazepine.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be decreased when it is combined with Carbamazepine.]
[G03BA03, testosterone, The metabolism of Carbamazepine can be increased when combined with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Carbamazepine can be decreased when combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AE05, lurasidone, The metabolism of Lurasidone can be increased when combined with Carbamazepine.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[N04BC07, apomorphine, The metabolism of Carbamazepine can be decreased when combined with Apomorphine.]
[L04AX02, thalidomide, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, The serum concentration of Theobromine can be decreased when it is combined with Carbamazepine.]
[R03DA04, theophylline, The serum concentration of Theophylline can be decreased when it is combined with Carbamazepine.]
[P02CA02, thiabendazole, The metabolism of Thiabendazole can be increased when combined with Carbamazepine.]
[L01XX41, eribulin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Eribulin.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be increased when combined with Carbamazepine.]
[L01BB03, thioguanine, The risk or severity of adverse effects can be increased when Tioguanine is combined with Carbamazepine.]
[N05CA19, thiopental, Carbamazepine may increase the Change in thyroid function activities of Thiopental.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Thioridazine.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be increased when combined with Carbamazepine.]
[G04BE06, moxisylyte, Moxisylyte may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AL03, tiapride, Tiapride may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tilidine.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[P01AB02, tinidazole, The metabolism of Tinidazole can be increased when combined with Carbamazepine.]
[S01AA12, tobramycin, Tobramycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tolperisone.]
[N02AX02, tramadol, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tranylcypromine.]
[C01DX11, trapidil, The risk or severity of bleeding can be increased when Trapidil is combined with Carbamazepine.]
[N06AX05, trazodone, The serum concentration of Trazodone can be decreased when it is combined with Carbamazepine.]
[L01XF01, tretinoin, The metabolism of Carbamazepine can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Carbamazepine can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The metabolism of Triamterene can be increased when combined with Carbamazepine.]
[N05CD05, triazolam, The metabolism of Carbamazepine can be decreased when combined with Triazolam.]
[C03AA06, trichlormethiazide, The risk or severity of adverse effects can be increased when Trichlormethiazide is combined with Carbamazepine.]
[A03AB12, mepenzolate, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[A16AX12, trientine, Triethylenetetramine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be increased when combined with Carbamazepine.]
[S01AD02, trifluridine, The risk or severity of adverse effects can be increased when Trifluridine is combined with Carbamazepine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Trifluperidol.]
[N05AA05, triflupromazine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[D07AC02, fluclorolone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fluclorolone.]
[N04AA01, trihexyphenidyl, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The metabolism of Carbamazepine can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The metabolism of Trimebutine can be increased when combined with Carbamazepine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Alimemazine.]
[N03AC02, trimethadione, Carbamazepine may increase the Change in thyroid function activities of Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be increased when combined with Carbamazepine.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be increased when combined with Carbamazepine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Carbamazepine.]
[A03BB01, butylscopolamine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Carbamazepine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be increased when combined with Carbamazepine.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Carbamazepine.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tubocurarine.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Carbamazepine.]
[L04AA26, belimumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Belimumab.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be increased when combined with Carbamazepine.]
[R02AA14, oxyquinoline, Oxyquinoline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Abiraterone can be increased when combined with Carbamazepine.]
[A10BH05, linagliptin, The metabolism of Carbamazepine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Carbamazepine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Carbamazepine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be decreased when it is combined with Carbamazepine.]
[B01AD04, urokinase, The risk or severity of bleeding can be increased when Urokinase is combined with Carbamazepine.]
[S01AA28, vancomycin, Vancomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA28, belatacept, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Belatacept.]
[N03AX21, ezogabine, The serum concentration of Ezogabine can be decreased when it is combined with Carbamazepine.]
[B01AF01, rivaroxaban, The serum concentration of Rivaroxaban can be decreased when it is combined with Carbamazepine.]
[R03AC18, indacaterol, The metabolism of Indacaterol can be increased when combined with Carbamazepine.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be increased when combined with Carbamazepine.]
[C08DA01, verapamil, The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Carbamazepine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be increased when combined with Carbamazepine.]
[L01CA02, vincristine, The metabolism of Vincristine can be increased when combined with Carbamazepine.]
[L01CA03, vindesine, The metabolism of Vindesine can be increased when combined with Carbamazepine.]
[B03BA01, vitamin B12, The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Carbamazepine.]
[A11HA03, vitamin E, The metabolism of Carbamazepine can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Warfarin can be increased when combined with Carbamazepine.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of adverse effects can be increased when Zidovudine is combined with Carbamazepine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be increased when combined with Carbamazepine.]
[J05AE02, indinavir, The serum concentration of Indinavir can be decreased when it is combined with Carbamazepine.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Levetiracetam is combined with Carbamazepine.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be increased when combined with Carbamazepine.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be increased when combined with Carbamazepine.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Carbamazepine can be decreased when combined with Crizotinib.]
[B01AE01, desirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Carbamazepine.]
[R03DC01, zafirlukast, The metabolism of Carbamazepine can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01XX02, asparaginase, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Asparaginase Escherichia coli.]
[N05AE04, ziprasidone, The serum concentration of Ziprasidone can be decreased when it is combined with Carbamazepine.]
[G03AC10, drospirenone, The serum concentration of Drospirenone can be decreased when it is combined with Carbamazepine.]
[V03AC02, deferiprone, Deferiprone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA34, alemtuzumab, The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Carbamazepine.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be increased when combined with Carbamazepine.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be increased when combined with Carbamazepine.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L03AB11, peginterferon alfa-2a, The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Carbamazepine.]
[L01FA01, rituximab, The risk or severity of adverse effects can be increased when Rituximab is combined with Carbamazepine.]
[J02AC03, voriconazole, The serum concentration of Voriconazole can be decreased when it is combined with Carbamazepine.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Atracurium.]
[S01FA01, atropine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be increased when combined with Carbamazepine.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Carbamazepine.]
[R07AX02, ivacaftor, The serum concentration of Ivacaftor can be decreased when it is combined with Carbamazepine.]
[H02AB11, prednylidene, The metabolism of Carbamazepine can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Peginesatide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01BC07, azacitidine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Azacitidine.]
[L04AX01, azathioprine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Azathioprine.]
[L01BC05, gemcitabine, The risk or severity of adverse effects can be increased when Gemcitabine is combined with Carbamazepine.]
[J01CA09, azlocillin, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Azlocillin.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Carbamazepine.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Carbamazepine.]
[L01FX02, gemtuzumab ozogamicin, The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carbamazepine.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be increased when combined with Carbamazepine.]
[G04BD12, mirabegron, The metabolism of Mirabegron can be increased when combined with Carbamazepine.]
[L01XG02, carfilzomib, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Carfilzomib.]
[V03AX03, cobicistat, The metabolism of Cobicistat can be increased when combined with Carbamazepine.]
[J05AJ02, elvitegravir, The metabolism of Elvitegravir can be increased when combined with Carbamazepine.]
[L02BB04, enzalutamide, The serum concentration of Carbamazepine can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be increased when combined with Carbamazepine.]
[L04AA31, teriflunomide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Teriflunomide.]
[A02AA05, magnesium silicate, Magnesium silicate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B01AX01, defibrotide, The risk or severity of bleeding can be increased when Defibrotide is combined with Carbamazepine.]
[L04AA22, abetimus, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Abetimus.]
[H02AA01, aldosterone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Aldosterone.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be increased when combined with Carbamazepine.]
[N05CA04, barbital, Carbamazepine may increase the Change in thyroid function activities of Barbital.]
[D02BA02, octinoxate, Octinoxate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AE04, nelfinavir, The serum concentration of Nelfinavir can be decreased when it is combined with Carbamazepine.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Carbamazepine.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Rasagiline.]
[C08CA13, lercanidipine, The metabolism of Carbamazepine can be decreased when combined with Lercanidipine.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mosapride.]
[N06DA02, donepezil, The metabolism of Donepezil can be increased when combined with Carbamazepine.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Carbamazepine.]
[L04AA29, tofacitinib, Carbamazepine may increase the immunosuppressive activities of Tofacitinib.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Carbamazepine.]
[R06AC06, thonzylamine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be increased when combined with Carbamazepine.]
[V09IX04, fluorodeoxyglucose F18, Fludeoxyglucose (18F) may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Diethyl ether.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be increased when combined with Carbamazepine.]
[H01CB05, pasireotide, The metabolism of Carbamazepine can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The metabolism of Carbamazepine can be decreased when combined with Sildenafil.]
[V08CA11, gadofosveset, Gadofosveset trisodium may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be increased when combined with Carbamazepine.]
[B01AF02, apixaban, The serum concentration of Apixaban can be decreased when it is combined with Carbamazepine.]
[A16AX08, teduglutide, Teduglutide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be increased when combined with Carbamazepine.]
[J04AK05, bedaquiline, The metabolism of Bedaquiline can be increased when combined with Carbamazepine.]
[C04AX11, bencyclane, The metabolism of Bencyclane can be increased when combined with Carbamazepine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be increased when combined with Carbamazepine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Carbamazepine can be increased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Carbamazepine.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be increased when combined with Carbamazepine.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be increased when combined with Carbamazepine.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Benperidol.]
[A10BK02, canagliflozin, The metabolism of Canagliflozin can be increased when combined with Carbamazepine.]
[L04AX07, dimethyl fumarate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dimethyl fumarate.]
[A12CC09, magnesium orotate, Magnesium orotate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AX06, tegaserod, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Benzocaine.]
[L03AA12, ancestim, Ancestim may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be increased when combined with Carbamazepine.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Naratriptan.]
[L04AA18, everolimus, The metabolism of Carbamazepine can be decreased when combined with Everolimus.]
[A12CC05, magnesium aspartate, Magnesium aspartate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Carbamazepine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EE01, trametinib, Trametinib may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Florbetapir (18F) may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be increased when combined with Carbamazepine.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be decreased when it is combined with Carbamazepine.]
[C08EA02, bepridil, The metabolism of Bepridil can be increased when combined with Carbamazepine.]
[C02KX05, riociguat, The metabolism of Riociguat can be increased when combined with Carbamazepine.]
[L03AA14, lipegfilgrastim, Carbamazepine may increase the myelosuppressive activities of Lipegfilgrastim.]
[A10BJ03, lixisenatide, Lixisenatide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G03XC02, bazedoxifene, The serum concentration of Bazedoxifene can be decreased when it is combined with Carbamazepine.]
[C02KX04, macitentan, The metabolism of Macitentan can be increased when combined with Carbamazepine.]
[L01EL01, ibrutinib, The metabolism of Carbamazepine can be decreased when combined with Ibrutinib.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be increased when combined with Carbamazepine.]
[G03AC08, etonogestrel, The serum concentration of Etonogestrel can be decreased when it is combined with Carbamazepine.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Carbamazepine can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Sofosbuvir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AG04, vigabatrin, Carbamazepine may increase the Change in thyroid function activities of Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be increased when combined with Carbamazepine.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Carbamazepine.]
[A16AA07, metreleptin, The metabolism of Carbamazepine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Carbamazepine can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Carbamazepine can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Carbamazepine can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be increased when combined with Carbamazepine.]
[B01AE03, argatroban, The risk or severity of bleeding can be increased when Argatroban is combined with Carbamazepine.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C10AB02, bezafibrate, The metabolism of Bezafibrate can be increased when combined with Carbamazepine.]
[L04AC11, siltuximab, The metabolism of Carbamazepine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be increased when combined with Carbamazepine.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be increased when combined with Carbamazepine.]
[L04AA33, vedolizumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Vedolizumab.]
[A03BA03, hyoscyamine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be increased when combined with Carbamazepine.]
[L01XH04, belinostat, The metabolism of Belinostat can be increased when combined with Carbamazepine.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be increased when combined with Carbamazepine.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Alfaxalone.]
[L03AB13, peginterferon beta-1a, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Peginterferon beta-1a.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[D11AA01, glycopyrronium, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CM19, suvorexant, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be increased when combined with Carbamazepine.]
[J01XA05, oritavancin, The metabolism of Carbamazepine can be increased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Acepromazine.]
[A06AH03, naloxegol, The metabolism of Naloxegol can be increased when combined with Carbamazepine.]
[L01BC08, decitabine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Decitabine.]
[N04AA02, biperiden, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[A11HA08, tocophersolan, The metabolism of Tocofersolan can be increased when combined with Carbamazepine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be increased when combined with Carbamazepine.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be increased when combined with Carbamazepine.]
[S03AA06, gentamicin, Gentamicin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01FX07, blinatumomab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Blinatumomab.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be increased when combined with Carbamazepine.]
[L01XK01, olaparib, The metabolism of Olaparib can be increased when combined with Carbamazepine.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Dicoumarol is combined with Carbamazepine.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be decreased when it is combined with Carbamazepine.]
[N06AX11, mirtazapine, Carbamazepine may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Carbamazepine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be increased when combined with Carbamazepine.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be increased when combined with Carbamazepine.]
[J05AP07, daclatasvir, The metabolism of Carbamazepine can be decreased when combined with Daclatasvir.]
[N02BE01, acetaminophen, The metabolism of Carbamazepine can be increased when combined with Acetaminophen.]
[L01DC01, bleomycin, The risk or severity of adverse effects can be increased when Bleomycin is combined with Carbamazepine.]
[A03AA09, difemerine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Tioclomarol is combined with Carbamazepine.]
[C01EB17, ivabradine, The metabolism of Ivabradine can be increased when combined with Carbamazepine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AP06, asunaprevir, The serum concentration of Asunaprevir can be decreased when it is combined with Carbamazepine.]
[A07DA06, eluxadoline, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Eluxadoline.]
[B01AC25, cangrelor, The risk or severity of bleeding can be increased when Cangrelor is combined with Carbamazepine.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be increased when combined with Carbamazepine.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be increased when combined with Carbamazepine.]
[A04AD14, rolapitant, The metabolism of Rolapitant can be increased when combined with Carbamazepine.]
[G02CX02, flibanserin, The metabolism of Flibanserin can be increased when combined with Carbamazepine.]
[A06AD03, magnesium peroxide, Magnesium peroxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be increased when combined with Carbamazepine.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01EC01, acetazolamide, The serum concentration of Carbamazepine can be increased when it is combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Acetophenazine.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be increased when combined with Carbamazepine.]
[V03AB37, idarucizumab, Idarucizumab may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be increased when combined with Carbamazepine.]
[R03DX09, mepolizumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mepolizumab.]
[J02AC05, isavuconazole, The metabolism of Carbamazepine can be increased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be increased when combined with Carbamazepine.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be decreased when it is combined with Carbamazepine.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be decreased when it is combined with Carbamazepine.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be increased when combined with Carbamazepine.]
[L01ED03, alectinib, The metabolism of Alectinib can be increased when combined with Carbamazepine.]
[B01AC27, selexipag, The metabolism of Selexipag can be increased when combined with Carbamazepine.]
[G04CA01, alfuzosin, The metabolism of Alfuzosin can be increased when combined with Carbamazepine.]
[M04AB05, lesinurad, The metabolism of Carbamazepine can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, The metabolism of Carbamazepine can be decreased when combined with Elbasvir.]
[J05AP11, grazoprevir, The metabolism of Grazoprevir can be increased when combined with Carbamazepine.]
[N05CA05, aprobarbital, The metabolism of Carbamazepine can be increased when combined with Aprobarbital.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A02AB06, aloglutamol, Aloglutamol can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AX23, brivaracetam, Carbamazepine may increase the Change in thyroid function activities of Brivaracetam.]
[L04AC13, ixekizumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ixekizumab.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be increased when combined with Carbamazepine.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be increased when combined with Carbamazepine.]
[N04BC01, bromocriptine, The metabolism of Bromocriptine can be increased when combined with Carbamazepine.]
[A02AD05, aluminum magnesium silicate, Almasilate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A02AB03, aluminum phosphate, Aluminium phosphate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Carbamazepine.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Amineptine.]
[C08CA01, amlodipine, The metabolism of Amlodipine can be increased when combined with Carbamazepine.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Carbamazepine.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Aniracetam.]
[C03CA02, bumetanide, Bumetanide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Bupivacaine.]
[N07BC01, buprenorphine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The metabolism of Carbamazepine can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The metabolism of Busulfan can be increased when combined with Carbamazepine.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Arsenic trioxide.]
[P01BE02, artemether, The metabolism of Carbamazepine can be decreased when combined with Artemether.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Butorphanol.]
[R06AX09, azatadine, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Azatadine.]
[S01GX07, azelastine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Carbamazepine can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be increased when combined with Carbamazepine.]
[L04AC12, brodalumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Brodalumab.]
[L01EF02, ribociclib, The metabolism of Carbamazepine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R03DA08, bamifylline, The serum concentration of Bamifylline can be decreased when it is combined with Carbamazepine.]
[L04AA36, ocrelizumab, Ocrelizumab may increase the immunosuppressive activities of Carbamazepine.]
[A06AH05, naldemedine, Naldemedine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The metabolism of Carbamazepine can be decreased when combined with Deutetrabenazine.]
[N03AX30, beclamide, Carbamazepine may increase the Change in thyroid function activities of Beclamide.]
[N06BC01, caffeine, The serum concentration of Caffeine can be decreased when it is combined with Carbamazepine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Carbamazepine can be increased when combined with Calcitriol.]
[P01CA02, benznidazole, Benznidazole may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AC01, daclizumab, The risk or severity of adverse effects can be increased when Daclizumab is combined with Carbamazepine.]
[J01XX08, linezolid, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Linezolid.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AE09, tipranavir, The serum concentration of Tipranavir can be decreased when it is combined with Carbamazepine.]
[N07XX13, valbenazine, The metabolism of Carbamazepine can be decreased when combined with Valbenazine.]
[L04AB02, infliximab, The metabolism of Carbamazepine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Carbamazepine can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be increased when combined with Carbamazepine.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Safinamide.]
[L04AC14, sarilumab, The metabolism of Carbamazepine can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, Delafloxacin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B01AF04, betrixaban, The risk or severity of bleeding can be increased when Betrixaban is combined with Carbamazepine.]
[L04AC16, guselkumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Guselkumab.]
[D01AC10, bifonazole, The metabolism of Carbamazepine can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Carbamazepine.]
[L01EH02, neratinib, The metabolism of Neratinib can be increased when combined with Carbamazepine.]
[L01XH01, vorinostat, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Vorinostat.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be increased when combined with Carbamazepine.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be increased when combined with Carbamazepine.]
[C07AB07, bisoprolol, The metabolism of Bisoprolol can be increased when combined with Carbamazepine.]
[J05AG03, efavirenz, The metabolism of Carbamazepine can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N04AA11, bornaprine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[L04AC02, basiliximab, The risk or severity of adverse effects can be increased when Basiliximab is combined with Carbamazepine.]
[L01BA03, raltitrexed, The risk or severity of adverse effects can be increased when Raltitrexed is combined with Carbamazepine.]
[V03AF08, palifermin, The therapeutic efficacy of Palifermin can be decreased when used in combination with Carbamazepine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Bromperidol.]
[N05CD09, brotizolam, The metabolism of Brotizolam can be increased when combined with Carbamazepine.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Carbamazepine can be increased when combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of bleeding can be increased when Buflomedil is combined with Carbamazepine.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be increased when combined with Carbamazepine.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Butobarbital.]
[J05AX18, letermovir, The metabolism of Carbamazepine can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Butriptyline.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Vinylbital.]
[R06AX18, acrivastine, Acrivastine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V04CD06, macimorelin, The metabolism of Macimorelin can be increased when combined with Carbamazepine.]
[L02BB05, apalutamide, The metabolism of Carbamazepine can be increased when combined with Apalutamide.]
[L04AA03, lymphocyte immune globulin, anti-thymocyte globulin, equine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Antilymphocyte immunoglobulin (horse).]
[S01AA13, fusidic acid, The metabolism of Carbamazepine can be decreased when combined with Fusidic acid.]
[A03AA03, camylofine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Carbinoxamine.]
[L03AB06, interferon alfa-n1, The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Carbamazepine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be increased when combined with Carbamazepine.]
[B02BX09, fostamatinib, The metabolism of Carbamazepine can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, Carbamazepine may increase the Change in thyroid function activities of Cannabidiol.]
[L04AA37, baricitinib, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Baricitinib.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be increased when combined with Carbamazepine.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be increased when combined with Carbamazepine.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01GB14, plazomicin, Plazomicin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[H01CC03, elagolix, The metabolism of Elagolix can be increased when combined with Carbamazepine.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be increased when combined with Carbamazepine.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Carbamazepine can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Carbamazepine can be increased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Carbamazepine can be decreased when combined with Doravirine.]
[J01AA13, eravacycline, The metabolism of Eravacycline can be increased when combined with Carbamazepine.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be increased when combined with Carbamazepine.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be increased when combined with Carbamazepine.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Chloroxylenol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R03DA02, oxtriphylline, The serum concentration of Oxtriphylline can be decreased when it is combined with Carbamazepine.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Carbamazepine.]
[R03BB08, revefenacin, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L01ED05, lorlatinib, The metabolism of Carbamazepine can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Carbamazepine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The risk or severity of adverse effects can be increased when Carmustine is combined with Carbamazepine.]
[L01EX12, larotrectinib, The metabolism of Larotrectinib can be increased when combined with Carbamazepine.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be increased when combined with Carbamazepine.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be increased when combined with Carbamazepine.]
[L04AA43, ravulizumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ravulizumab.]
[A06AX05, prucalopride, The metabolism of Prucalopride can be increased when combined with Carbamazepine.]
[B01AX07, caplacizumab, The risk or severity of bleeding can be increased when Caplacizumab is combined with Carbamazepine.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Carbamazepine.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Carbamazepine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Esketamine.]
[L04AA42, siponimod, The therapeutic efficacy of Siponimod can be decreased when used in combination with Carbamazepine.]
[J01FA09, clarithromycin, The metabolism of Carbamazepine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Solriamfetol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AX29, brexanolone, Carbamazepine may increase the Change in thyroid function activities of Brexanolone.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be increased when combined with Carbamazepine.]
[N05BA09, clobazam, Carbamazepine may increase the Change in thyroid function activities of Clobazam.]
[H02AB14, cloprednol, The metabolism of Carbamazepine can be increased when combined with Cloprednol.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cloxazolam.]
[L04AB01, etanercept, The metabolism of Carbamazepine can be increased when combined with Etanercept.]
[A12CC06, magnesium lactate, Magnesium lactate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02AB17, cortivazol, The metabolism of Carbamazepine can be increased when combined with Cortivazol.]
[L04AC18, risankizumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Risankizumab.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be decreased when it is combined with Carbamazepine.]
[L01FX14, polatuzumab vedotin, The risk or severity of adverse effects can be decreased when Carbamazepine is combined with Polatuzumab vedotin.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01XX66, selinexor, The metabolism of Selinexor can be increased when combined with Carbamazepine.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be decreased when it is combined with Carbamazepine.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be increased when combined with Carbamazepine.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cyamemazine.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Carbamazepine.]
[L04AA44, upadacitinib, The metabolism of Upadacitinib can be increased when combined with Carbamazepine.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be increased when combined with Carbamazepine.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be increased when combined with Carbamazepine.]
[N07XX11, pitolisant, The metabolism of Pitolisant can be increased when combined with Carbamazepine.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be increased when combined with Carbamazepine.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be increased when combined with Carbamazepine.]
[N04CX01, istradefylline, The metabolism of Carbamazepine can be decreased when combined with Istradefylline.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be increased when combined with Carbamazepine.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be increased when combined with Carbamazepine.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DB09, cephradine, The metabolism of Carbamazepine can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be decreased when it is combined with Carbamazepine.]
[G03DB05, demegestone, The serum concentration of Demegestone can be decreased when it is combined with Carbamazepine.]
[L01FD01, trastuzumab, Trastuzumab may increase the neutropenic activities of Carbamazepine.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Carbamazepine.]
[L04AX09, diroximel fumarate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Diroximel fumarate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be increased when combined with Carbamazepine.]
[G03AC09, desogestrel, The serum concentration of Desogestrel can be decreased when it is combined with Carbamazepine.]
[B06AX03, voxelotor, The serum concentration of Carbamazepine can be increased when it is combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Carbamazepine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M09AX08, golodirsen, Golodirsen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be decreased when it is combined with Carbamazepine.]
[L01FX13, enfortumab vedotin, The metabolism of Enfortumab vedotin can be increased when combined with Carbamazepine.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Carbamazepine.]
[R06AB02, dexchlorpheniramine, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Dexchlorpheniramine.]
[S01XA12, dexpanthenol, Dexpanthenol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dezocine.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be increased when combined with Carbamazepine.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be decreased when it is combined with Carbamazepine.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be increased when combined with Carbamazepine.]
[L04AA53, teprotumumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Teprotumumab.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be decreased when it is combined with Carbamazepine.]
[N02CD06, rimegepant, The metabolism of Rimegepant can be increased when combined with Carbamazepine.]
[J05AB16, remdesivir, The metabolism of Carbamazepine can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The serum concentration of Osilodrostat can be decreased when it is combined with Carbamazepine.]
[J05AE05, amprenavir, The serum concentration of Amprenavir can be decreased when it is combined with Carbamazepine.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be increased when combined with Carbamazepine.]
[G04CB02, dutasteride, The metabolism of Carbamazepine can be decreased when combined with Dutasteride.]
[L04AA38, ozanimod, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ozanimod.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be decreased when it is combined with Carbamazepine.]
[R02AA03, dichlorobenzyl alcohol, Dichlorobenzyl alcohol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G03DB08, dienogest, The metabolism of Dienogest can be increased when combined with Carbamazepine.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be increased when combined with Carbamazepine.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be increased when combined with Carbamazepine.]
[M01AH02, rofecoxib, The metabolism of Carbamazepine can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Carbamazepine can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Carbamazepine can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be increased when combined with Carbamazepine.]
[N03AG02, dipropylacetamide, Carbamazepine may increase the Change in thyroid function activities of Valpromide.]
[J01FA13, dirithromycin, The metabolism of Carbamazepine can be decreased when combined with Dirithromycin.]
[L01AA02, chlorambucil, The risk or severity of adverse effects can be increased when Chlorambucil is combined with Carbamazepine.]
[S03AA08, chloramphenicol, The metabolism of Carbamazepine can be decreased when combined with Chloramphenicol.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Carbamazepine.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be increased when combined with Carbamazepine.]
[L01FX17, sacituzumab govitecan, The serum concentration of Sacituzumab govitecan can be decreased when it is combined with Carbamazepine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be increased when combined with Carbamazepine.]
[A03AA08, dihexyverine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be decreased when it is combined with Carbamazepine.]
[D07XB03, fluprednidene, The metabolism of Carbamazepine can be increased when combined with Fluprednidene.]
[G04BD09, trospium, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be decreased when it is combined with Carbamazepine.]
[V08CA05, mangafodipir, Mangafodipir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be decreased when it is combined with Carbamazepine.]
[B01AE02, lepirudin, The risk or severity of bleeding can be increased when Lepirudin is combined with Carbamazepine.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CM02, chlormethiazole, Carbamazepine may increase the Change in thyroid function activities of Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Chlormezanone.]
[L04AA47, inebilizumab, The risk or severity of infection can be increased when Carbamazepine is combined with Inebilizumab.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Dyclonine.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be decreased when it is combined with Carbamazepine.]
[R05CB11, stepronin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Stepronin.]
[C08CA17, levamlodipine, The metabolism of Carbamazepine can be decreased when combined with Levamlodipine.]
[R06AX22, ebastine, The metabolism of Ebastine can be increased when combined with Carbamazepine.]
[J05AX29, fostemsavir, The serum concentration of Fostemsavir can be decreased when it is combined with Carbamazepine.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Carbamazepine.]
[N05CD14, remimazolam, The risk or severity of sedation can be increased when Carbamazepine is combined with Remimazolam.]
[N07XX04, sodium oxybate, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[L04AC19, satralizumab, The serum concentration of Carbamazepine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Carbamazepine is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Carbamazepine can be decreased when combined with Chloroquine.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be decreased when it is combined with Carbamazepine.]
[C03AA04, chlorothiazide, The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Carbamazepine.]
[R06AB04, chlorpheniramine, The metabolism of Carbamazepine can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, The metabolism of Carbamazepine can be increased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AF03, chlorprothixene, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[C03BA04, chlorthalidone, The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Carbamazepine.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be increased when combined with Carbamazepine.]
[A11CC05, cholecalciferol, The metabolism of Cholecalciferol can be increased when combined with Carbamazepine.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Etifoxine.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02BA03, choline salicylate, Choline salicylate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06BX18, vinpocetine, Carbamazepine may increase the Change in thyroid function activities of Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ethyl loflazepate.]
[G03DC06, ethynodiol, The serum concentration of Etynodiol can be decreased when it is combined with Carbamazepine.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B06AC06, berotralstat, The serum concentration of Carbamazepine can be increased when it is combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Carbamazepine can be decreased when combined with Lonafarnib.]
[L01BB05, fludarabine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fludarabine.]
[L02BX04, relugolix, The serum concentration of Relugolix can be decreased when it is combined with Carbamazepine.]
[M01AX25, chondroitin sulfates, Chondroitin sulfate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AJ04, cabotegravir, The serum concentration of Cabotegravir can be decreased when it is combined with Carbamazepine.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be increased when combined with Carbamazepine.]
[P03AX07, abametapir, The serum concentration of Carbamazepine can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be decreased when it is combined with Carbamazepine.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Febarbamate.]
[N03AX10, felbamate, The serum concentration of Felbamate can be decreased when it is combined with Carbamazepine.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06BA10, fenethylline, The serum concentration of Fenethylline can be decreased when it is combined with Carbamazepine.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G04CB01, finasteride, The metabolism of Carbamazepine can be decreased when combined with Finasteride.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R03BA03, flunisolide, The metabolism of Carbamazepine can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Carbamazepine can be increased when combined with Fluocinolone acetonide.]
[N02BG07, flupirtine, Flupirtine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Carbamazepine.]
[L04AA50, ponesimod, The metabolism of Carbamazepine can be decreased when combined with Ponesimod.]
[L01EK03, tivozanib, The metabolism of Tivozanib can be increased when combined with Carbamazepine.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Carbamazepine.]
[B03AB10, ferric maltol, The metabolism of Ferric maltol can be increased when combined with Carbamazepine.]
[A02BA01, cimetidine, The metabolism of Carbamazepine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, Carbamazepine may increase the Change in thyroid function activities of Gabapentin.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be increased when combined with Carbamazepine.]
[L01XX73, sotorasib, The serum concentration of Sotorasib can be decreased when it is combined with Carbamazepine.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be increased when combined with Carbamazepine.]
[S03AA07, ciprofloxacin, The serum concentration of Carbamazepine can be increased when it is combined with Ciprofloxacin.]
[L01XA01, cisplatin, The risk or severity of adverse effects can be increased when Cisplatin is combined with Carbamazepine.]
[N06AB04, citalopram, Carbamazepine may increase the QTc-prolonging activities of Citalopram.]
[L04AA54, pegcetacoplan, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pegcetacoplan.]
[J02AX07, ibrexafungerp, The serum concentration of Ibrexafungerp can be decreased when it is combined with Carbamazepine.]
[C03DA05, finerenone, The therapeutic efficacy of Finerenone can be decreased when used in combination with Carbamazepine.]
[L04AA48, belumosudil, The serum concentration of Belumosudil can be decreased when it is combined with Carbamazepine.]
[P01CA03, fexinidazole, The metabolism of Carbamazepine can be decreased when combined with Fexinidazole.]
[L04AA51, anifrolumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Anifrolumab.]
[L01XX74, belzutifan, The serum concentration of Carbamazepine can be decreased when it is combined with Belzutifan.]
[L01EB10, mobocertinib, The serum concentration of Mobocertinib can be decreased when it is combined with Carbamazepine.]
[L01FX23, tisotumab vedotin, The metabolism of Tisotumab vedotin can be increased when combined with Carbamazepine.]
[N02CD07, atogepant, The serum concentration of Atogepant can be decreased when it is combined with Carbamazepine.]
[L04AA59, avacopan, The metabolism of Carbamazepine can be decreased when combined with Avacopan.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Carbamazepine.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be increased when combined with Carbamazepine.]
[J01FF01, clindamycin, The metabolism of Carbamazepine can be decreased when combined with Clindamycin.]
[N06AX25, St. John's wort extract, The metabolism of Carbamazepine can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Carbamazepine can be increased when it is combined with Asciminib.]
[L02BG06, exemestane, The metabolism of Exemestane can be increased when combined with Carbamazepine.]
[J05AX10, maribavir, The serum concentration of Maribavir can be decreased when it is combined with Carbamazepine.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Carbamazepine.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Carbamazepine.]
[J04BA01, clofazimine, The metabolism of Carbamazepine can be decreased when combined with Clofazimine.]
[B01AD11, tenecteplase, The risk or severity of bleeding can be increased when Tenecteplase is combined with Carbamazepine.]
[C10AB01, clofibrate, The metabolism of Carbamazepine can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be increased when combined with Carbamazepine.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be decreased when it is combined with Carbamazepine.]
[N06AA04, clomipramine, The serum concentration of Clomipramine can be increased when it is combined with Carbamazepine.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be increased when combined with Carbamazepine.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Carbamazepine.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be decreased when it is combined with Carbamazepine.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Carbamazepine.]
[N03AX27, ganaxolone, The metabolism of Ganaxolone can be increased when combined with Carbamazepine.]
[L04AC22, spesolimab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Spesolimab.]
[L04AA56, deucravacitinib, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Deucravacitinib.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Clothiapine.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be increased when combined with Carbamazepine.]
[A04AA01, ondansetron, The metabolism of Carbamazepine can be decreased when combined with Ondansetron.]
[A04AA02, granisetron, The metabolism of Granisetron can be increased when combined with Carbamazepine.]
[J05AX31, lenacapavir, The metabolism of Lenacapavir can be increased when combined with Carbamazepine.]
[L01XX77, adagrasib, The serum concentration of Adagrasib can be decreased when it is combined with Carbamazepine.]
[N05AH02, clozapine, The risk or severity of neutropenia can be increased when Carbamazepine is combined with Clozapine.]
[L01EN04, futibatinib, The metabolism of Futibatinib can be increased when combined with Carbamazepine.]
[A10BK06, sotagliflozin, The serum concentration of Sotagliflozin can be decreased when it is combined with Carbamazepine.]
[J01GB12, arbekacin, Arbekacin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Carbamazepine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Cocaine.]
[M09AX11, palovarotene, The serum concentration of Palovarotene can be decreased when it is combined with Carbamazepine.]
[C02KB01, metyrosine, Carbamazepine may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Carbamazepine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R05DA04, codeine, The metabolism of Codeine can be increased when combined with Carbamazepine.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Hexafluronium.]
[M04AC01, colchicine, The metabolism of Colchicine can be increased when combined with Carbamazepine.]
[A03AB10, hexocyclium, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[J01XB01, colistin, Colistin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Leflunomide.]
[A02AD04, hydrotalcite, Hydrotalcite can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desflurane.]
[A04AA03, tropisetron, Tropisetron may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C04AX28, ifenprodil, Carbamazepine may increase the Change in thyroid function activities of Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Carbamazepine can be decreased when combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01BB07, nelarabine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nelarabine.]
[J01FA15, telithromycin, The metabolism of Carbamazepine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ciclesonide.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desloratadine.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C05BB03, invert sugar, Invert sugar may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V08AB05, iopromide, Iopromide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V08AB07, ioversol, Ioversol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V08AB12, ioxilan, Ioxilan may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be increased when combined with Carbamazepine.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be increased when combined with Carbamazepine.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be increased when combined with Carbamazepine.]
[J02AC02, itraconazole, The metabolism of Carbamazepine can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The risk or severity of bleeding can be increased when Bemiparin is combined with Carbamazepine.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be increased when combined with Carbamazepine.]
[N05BA10, ketazolam, The metabolism of Carbamazepine can be decreased when combined with Ketazolam.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L02BA03, fulvestrant, The metabolism of Fulvestrant can be increased when combined with Carbamazepine.]
[L01EA01, imatinib, The metabolism of Imatinib can be increased when combined with Carbamazepine.]
[J02AC04, posaconazole, The metabolism of Carbamazepine can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be increased when combined with Carbamazepine.]
[C08CA09, lacidipine, The metabolism of Lacidipine can be increased when combined with Carbamazepine.]
[N03AX09, lamotrigine, The metabolism of Lamotrigine can be increased when combined with Carbamazepine.]
[S01BA03, cortisone, The metabolism of Carbamazepine can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Lofexidine.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be increased when combined with Carbamazepine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R06AX13, loratadine, The metabolism of Loratadine can be increased when combined with Carbamazepine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Lormetazepam.]
[H01AA02, cosyntropin, The risk or severity of liver damage can be increased when Tetracosactide is combined with Carbamazepine.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A02AD02, magaldrate, Magaldrate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AD01, magnesium carbonate, Magnesium carbonate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C08CA11, manidipine, The metabolism of Carbamazepine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Medifoxamine.]
[H02AB15, meprednisone, The metabolism of Carbamazepine can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Carbamazepine can be decreased when combined with Mequitazine.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01EB10, adenosine, Carbamazepine may increase the atrioventricular blocking (AV block) activities of Adenosine.]
[R06AD04, methdilazine, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Methdilazine.]
[N04AA03, methixene, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[C04AX01, cyclandelate, The metabolism of Cyclandelate can be increased when combined with Carbamazepine.]
[R03CB02, methoxyphenamine, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Methoxyphenamine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cyclobarbital.]
[C03DA04, eplerenone, The metabolism of Carbamazepine can be decreased when combined with Eplerenone.]
[N05AD03, metylperon, Melperone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA15, alefacept, The risk or severity of adverse effects can be increased when Alefacept is combined with Carbamazepine.]
[C03AA07, cyclopenthiazide, The risk or severity of adverse effects can be increased when Cyclopenthiazide is combined with Carbamazepine.]
[J01FA03, midecamycin, The metabolism of Carbamazepine can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be decreased when it is combined with Carbamazepine.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be increased when combined with Carbamazepine.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Minaprine.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Moclobemide.]
[N06BA07, modafinil, The metabolism of Carbamazepine can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C10AA07, rosuvastatin, The metabolism of Carbamazepine can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Carbamazepine can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Entecavir can be increased when combined with Carbamazepine.]
[G04BE09, vardenafil, The metabolism of Carbamazepine can be decreased when combined with Vardenafil.]
[M01AH05, etoricoxib, The metabolism of Carbamazepine can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dacarbazine.]
[L01DA01, dactinomycin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dactinomycin.]
[G03XA01, danazol, The metabolism of Carbamazepine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dantrolene.]
[J04BA02, dapsone, The metabolism of Carbamazepine can be decreased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Carbamazepine can be decreased when combined with Daunorubicin.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Deanol.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be increased when combined with Carbamazepine.]
[N07BB05, nalmefene, Nalmefene may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be increased when combined with Carbamazepine.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AX06, nefazodone, The serum concentration of Nefazodone can be decreased when it is combined with Carbamazepine.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Niaprazine.]
[C01DX16, nicorandil, Nicorandil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AG06, tiagabine, Carbamazepine may increase the Change in thyroid function activities of Tiagabine.]
[G03DB04, nomegestrol, The serum concentration of Nomegestrol can be decreased when it is combined with Carbamazepine.]
[C01CA23, theodrenaline, The serum concentration of Theodrenaline can be decreased when it is combined with Carbamazepine.]
[M03AC11, cisatracurium, Carbamazepine may decrease the neuromuscular blocking activities of Cisatracurium.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Normethadone.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[D11AH02, pimecrolimus, The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Carbamazepine.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be increased when combined with Carbamazepine.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AA01, desipramine, The metabolism of Carbamazepine can be decreased when combined with Desipramine.]
[H01BA02, desmopressin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desmopressin.]
[D07XC02, desoximetasone, The risk or severity of adverse effects can be increased when Desoximetasone is combined with Carbamazepine.]
[V04CH02, indigo carmine, Indigotindisulfonic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C09XA02, aliskiren, The metabolism of Aliskiren can be increased when combined with Carbamazepine.]
[L01XA03, oxaliplatin, The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Carbamazepine.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Carbamazepine resulting in a loss in efficacy.]
[S03BA01, dexamethasone, The metabolism of Carbamazepine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Oxiracetam.]
[N04AA08, dexetimide, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, The metabolism of Carbamazepine can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be increased when combined with Carbamazepine.]
[A03AA01, oxyphencyclimine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Carbamazepine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be increased when combined with Carbamazepine.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R05DA09, dextromethorphan, The metabolism of Carbamazepine can be decreased when combined with Dextromethorphan.]
[N03AC01, paramethadione, Carbamazepine may increase the Change in thyroid function activities of Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dextromoramide.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be increased when combined with Carbamazepine.]
[B01AC04, clopidogrel, The metabolism of Carbamazepine can be decreased when combined with Clopidogrel.]
[N07BC06, heroin, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Diamorphine.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C04AD01, pentifylline, The serum concentration of Pentifylline can be decreased when it is combined with Carbamazepine.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05BA01, diazepam, Carbamazepine may increase the Change in thyroid function activities of Diazepam.]
[N03AX07, phenacemide, Carbamazepine may increase the Change in thyroid function activities of Phenacemide.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Phenol.]
[N03AD02, phensuximide, Carbamazepine may increase the Change in thyroid function activities of Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dibenzepin.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Cinchocaine.]
[R05DA08, pholcodine, Pholcodine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be increased when combined with Carbamazepine.]
[J01CF01, dicloxacillin, The metabolism of Carbamazepine can be increased when combined with Dicloxacillin.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C02DG01, pinacidil, The metabolism of Pinacidil can be increased when combined with Carbamazepine.]
[A03AX04, pinaverium, The metabolism of Pinaverium can be increased when combined with Carbamazepine.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be increased when combined with Carbamazepine.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pipamperone.]
[A03AB14, pipenzolate, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01DC04, ixabepilone, The metabolism of Carbamazepine can be decreased when combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be increased when combined with Carbamazepine.]
[L01DB08, pirarubicin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pirarubicin.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Diethylpropion.]
[L02AA01, diethylstilbestrol, The serum concentration of Diethylstilbestrol can be decreased when it is combined with Carbamazepine.]
[C08CA03, isradipine, The metabolism of Carbamazepine can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Carbamazepine can be increased when combined with Difluocortolone.]
[A03AB11, poldine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be increased when combined with Carbamazepine.]
[C01AA05, digoxin, Digoxin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be increased when combined with Carbamazepine.]
[C10AX09, ezetimibe, The metabolism of Ezetimibe can be increased when combined with Carbamazepine.]
[L01XX24, pegaspargase, The risk or severity of adverse effects can be increased when Pegaspargase is combined with Carbamazepine.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be increased when combined with Carbamazepine.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be increased when combined with Carbamazepine.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AX04, lenalidomide, The risk or severity of adverse effects can be increased when Lenalidomide is combined with Carbamazepine.]
[J05AE08, atazanavir, The serum concentration of Atazanavir can be decreased when it is combined with Carbamazepine.]
[H03BC01, potassium perchlorate, Potassium perchlorate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Carbamazepine can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dimenhydrinate.]
[V03AB09, dimercaprol, Dimercaprol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pridinol.]
[R06AB03, dimethindene, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, The metabolism of Carbamazepine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, Carbamazepine may increase the Change in thyroid function activities of Progabide.]
[N06BC02, propentofylline, The serum concentration of Propentofylline can be decreased when it is combined with Carbamazepine.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C05CA03, diosmin, The metabolism of Carbamazepine can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Proparacaine.]
[R03DA03, proxyphylline, The serum concentration of Proxyphylline can be decreased when it is combined with Carbamazepine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Diphenoxylate.]
[N05CD10, quazepam, The metabolism of Quazepam can be increased when combined with Carbamazepine.]
[B01AC07, dipyridamole, The risk or severity of bleeding can be increased when Dipyridamole is combined with Carbamazepine.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dexmethylphenidate.]
[B01AD10, drotrecogin alfa, The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Carbamazepine.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Quinupramine.]
[A03FA02, cisapride, The metabolism of Carbamazepine can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The metabolism of Carbamazepine can be decreased when combined with Sirolimus.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Carbamazepine.]
[S01AX06, resorcinol, Resorcinol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01BA03, disopyramide, The metabolism of Disopyramide can be increased when combined with Carbamazepine.]
[L04AA23, natalizumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Natalizumab.]
[P03AA04, disulfiram, The metabolism of Carbamazepine can be decreased when combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Carbamazepine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Carbamazepine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, Carbamazepine may increase the Change in thyroid function activities of Riluzole.]
[N05AX08, risperidone, The serum concentration of Risperidone can be decreased when it is combined with Carbamazepine.]
[R06AE09, levocetirizine, The metabolism of Levocetirizine can be increased when combined with Carbamazepine.]
[L04AA21, efalizumab, The risk or severity of adverse effects can be increased when Efalizumab is combined with Carbamazepine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be increased when combined with Carbamazepine.]
[A04AD12, aprepitant, The metabolism of Carbamazepine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be increased when combined with Carbamazepine.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Carbamazepine.]
[J05AE07, fosamprenavir, The serum concentration of Fosamprenavir can be decreased when it is combined with Carbamazepine.]
[G04BE08, tadalafil, The metabolism of Carbamazepine can be decreased when combined with Tadalafil.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C02KX02, ambrisentan, The metabolism of Carbamazepine can be decreased when combined with Ambrisentan.]
[C01EB18, ranolazine, The metabolism of Ranolazine can be increased when combined with Carbamazepine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R03AC12, salmeterol, The metabolism of Carbamazepine can be decreased when combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A03FA03, domperidone, The metabolism of Carbamazepine can be decreased when combined with Domperidone.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AA16, dothiepin, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be increased when combined with Carbamazepine.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be increased when combined with Carbamazepine.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[N06AB06, sertraline, The metabolism of Sertraline can be increased when combined with Carbamazepine.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[A08AA10, sibutramine, The metabolism of Sibutramine can be increased when combined with Carbamazepine.]
[C10AA01, simvastatin, The metabolism of Carbamazepine can be decreased when combined with Simvastatin.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Sodium phosphate, monobasic.]
[A12CA02, sodium sulfate, Sodium sulfate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G03DB01, dydrogesterone, The metabolism of Dydrogesterone can be increased when combined with Carbamazepine.]
[R03DA01, dyphylline, The serum concentration of Dyphylline can be decreased when it is combined with Carbamazepine.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Sultopride.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[H01AA01, corticotropin, The metabolism of Carbamazepine can be increased when combined with Corticotropin.]
[J01MA05, temafloxacin, The metabolism of Temafloxacin can be increased when combined with Carbamazepine.]
[L01AX03, temozolomide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Temozolomide.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[D01BA02, terbinafine, The metabolism of Carbamazepine can be increased when combined with Terbinafine.]
[G04BD05, terodiline, The metabolism of Terodiline can be increased when combined with Carbamazepine.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Thiopropazate.]
[G04BD01, emepronium, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be increased when combined with Carbamazepine.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tofisopam.]
[M01AG02, tolfenamic acid, The metabolism of Tolfenamic acid can be increased when combined with Carbamazepine.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Toloxatone.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be decreased when used in combination with Carbamazepine.]
[L02BA02, toremifene, The metabolism of Toremifene can be increased when combined with Carbamazepine.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Loprazolam.]
[N05CC01, chloral hydrate, Chloral hydrate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Triclofos.]
[A03AB08, tridihexethyl, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[B01AC18, triflusal, The risk or severity of bleeding can be increased when Triflusal is combined with Carbamazepine.]
[H02CA01, trilostane, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Trilostane.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Trimethobenzamide.]
[L01AA07, trofosfamide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Trofosfamide.]
[N04AA12, tropatepine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[C05CA04, troxerutin, The risk or severity of bleeding can be increased when Troxerutin is combined with Carbamazepine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Carbamazepine.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Urapidil.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be increased when combined with Carbamazepine.]
[S01GX10, epinastine, The metabolism of Epinastine can be increased when combined with Carbamazepine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Carbamazepine can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Carbamazepine can be decreased when combined with Epinephrine.]
[B05XA12, zinc chloride, Zinc chloride can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L01DB03, epirubicin, The risk or severity of adverse effects can be increased when Epirubicin is combined with Carbamazepine.]
[B05XA18, zinc sulfate, Zinc sulfate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CF02, zolpidem, Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[M01AB04, zomepirac, The metabolism of Zomepirac can be increased when combined with Carbamazepine.]
[N03AX15, zonisamide, Carbamazepine may increase the Change in thyroid function activities of Zonisamide.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be increased when combined with Carbamazepine.]
[N05AX11, zotepine, The metabolism of Zotepine can be increased when combined with Carbamazepine.]
[B01AD03, anistreplase, The risk or severity of bleeding can be increased when Anistreplase is combined with Carbamazepine.]
[L01XA02, carboplatin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Carboplatin.]
[C02AC02, guanfacine, The metabolism of Guanfacine can be increased when combined with Carbamazepine.]
[B01AC11, iloprost, The risk or severity of bleeding can be increased when Iloprost is combined with Carbamazepine.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Moricizine.]
[G02AB03, ergonovine, The metabolism of Ergometrine can be increased when combined with Carbamazepine.]
[C04AE01, ergoloid mesylates, USP, The metabolism of Ergoloid mesylate can be increased when combined with Carbamazepine.]
[N02CA02, ergotamine, The metabolism of Carbamazepine can be decreased when combined with Ergotamine.]
[L03AX05, pidotimod, Pidotimod may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Carbamazepine can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Carbamazepine may increase the Change in thyroid function activities of Estazolam.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be increased when combined with Carbamazepine.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be increased when combined with Carbamazepine.]
[G03CA03, estradiol, The serum concentration of Estradiol can be decreased when it is combined with Carbamazepine.]
[L01XX11, estramustine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Estramustine.]
[G03CC06, estriol, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Estriol.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be increased when combined with Carbamazepine.]
[J04AK02, ethambutol, The metabolism of Carbamazepine can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Carbamazepine can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Carbamazepine can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Carbamazepine can be decreased when combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01CA15, gepefrine, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Gepefrine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Carbamazepine.]
[L02AA03, ethinyl estradiol, The serum concentration of Ethinylestradiol can be decreased when it is combined with Carbamazepine.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N04AA05, profenamine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, Carbamazepine may increase the Change in thyroid function activities of Ethosuximide.]
[N03AB01, ethotoin, Carbamazepine may increase the Change in thyroid function activities of Ethotoin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be increased when combined with Carbamazepine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Carbamazepine.]
[N05AE03, sertindole, The metabolism of Sertindole can be increased when combined with Carbamazepine.]
[L04AD02, tacrolimus, Tacrolimus may increase the immunosuppressive activities of Carbamazepine.]
[R06AX11, astemizole, The metabolism of Astemizole can be increased when combined with Carbamazepine.]
[R06AX12, terfenadine, The metabolism of Carbamazepine can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Carbamazepine can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, The metabolism of Tocainide can be increased when combined with Carbamazepine.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA02, muromonab-CD3, The risk or severity of adverse effects can be increased when Muromonab is combined with Carbamazepine.]
[M01CB01, gold sodium thiomalate, Sodium aurothiomalate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A05AA01, chenodeoxycholic acid, The metabolism of Chenodeoxycholic acid can be increased when combined with Carbamazepine.]
[B05AA05, dextran, Dextran may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V03AF02, dexrazoxane, The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Carbamazepine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Carbamazepine.]
[C08CA02, felodipine, The metabolism of Carbamazepine can be decreased when combined with Felodipine.]
[C08EA01, fendiline, The metabolism of Fendiline can be increased when combined with Carbamazepine.]
[N03AX26, fenfluramine, The serum concentration of Fenfluramine can be decreased when it is combined with Carbamazepine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be increased when combined with Carbamazepine.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B01AD05, plasmin, The risk or severity of bleeding can be increased when Fibrinolysin is combined with Carbamazepine.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Clofarabine.]
[L04AA40, cladribine, The risk or severity of adverse effects can be increased when Cladribine is combined with Carbamazepine.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be increased when combined with Carbamazepine.]
[G04BD02, flavoxate, Flavoxate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Flecainide can be increased when combined with Carbamazepine.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01CF05, floxacillin, The metabolism of Carbamazepine can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Carbamazepine can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Flucytosine.]
[H02AA02, fludrocortisone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fludrocortisone.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[D07XB01, flumethasone, The metabolism of Flumethasone can be increased when combined with Carbamazepine.]
[N07CA03, flunarizine, The serum concentration of Flunarizine can be decreased when it is combined with Carbamazepine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be increased when combined with Carbamazepine.]
[D07AC08, fluocinonide, The metabolism of Carbamazepine can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Melitracen.]
[H02AB03, fluocortolone, The metabolism of Carbamazepine can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, The risk or severity of adverse effects can be increased when Floxuridine is combined with Carbamazepine.]
[S01CB05, fluorometholone, The risk or severity of adverse effects can be increased when Fluorometholone is combined with Carbamazepine.]
[L01BC02, fluorouracil, The risk or severity of adverse effects can be increased when Fluorouracil is combined with Carbamazepine.]
[N06AB03, fluoxetine, The serum concentration of Carbamazepine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of myelosuppression can be increased when Flupentixol is combined with Carbamazepine.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Fluphenazine.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be increased when combined with Carbamazepine.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AG01, fluspirilene, The metabolism of Fluspirilene can be increased when combined with Carbamazepine.]
[L02BB01, flutamide, The metabolism of Carbamazepine can be decreased when combined with Flutamide.]
[V04CX02, folic acid, The serum concentration of Folic acid can be decreased when it is combined with Carbamazepine.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Carbamazepine.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Furazolidone.]
[J05AE10, darunavir, The serum concentration of Carbamazepine can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, Furosemide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Carbamazepine is combined with Eszopiclone.]
[D10AX01, aluminum chloride, Aluminum chloride can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be increased when combined with Carbamazepine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Gallamine.]
[C08DA02, gallopamil, The metabolism of Gallopamil can be increased when combined with Carbamazepine.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AA04, barbexaclone, Carbamazepine may increase the Change in thyroid function activities of Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Bifemelane.]
[C10AB04, gemfibrozil, The metabolism of Gemfibrozil can be increased when combined with Carbamazepine.]
[J01XA03, telavancin, Telavancin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Carbamazepine.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be increased when combined with Carbamazepine.]
[C01CA21, cafedrine, The serum concentration of Cafedrine can be decreased when it is combined with Carbamazepine.]
[J05AG04, etravirine, The metabolism of Carbamazepine can be increased when combined with Etravirine.]
[N03AD03, methsuximide, Carbamazepine may increase the Change in thyroid function activities of Methsuximide.]
[G03XA02, gestrinone, The serum concentration of Gestrinone can be decreased when it is combined with Carbamazepine.]
[N01AH02, alfentanil, The metabolism of Carbamazepine can be decreased when combined with Alfentanil.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be increased when combined with Carbamazepine.]
[A10BB01, glyburide, The metabolism of Carbamazepine can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Carbamazepine.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Glutethimide.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be increased when combined with Carbamazepine.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be increased when combined with Carbamazepine.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Carbamazepine.]
[M01CB04, aurothioglucose, Aurothioglucose may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Fluindione is combined with Carbamazepine.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[D01BA01, griseofulvin, The metabolism of Carbamazepine can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Carbamazepine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The metabolism of Haloperidol can be increased when combined with Carbamazepine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Halothane.]
[N05AH04, quetiapine, The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Quetiapine.]
[N06BX13, idebenone, Idebenone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Iprazochrome.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be increased when combined with Carbamazepine.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Allobarbital.]
[M04AA01, allopurinol, The risk or severity of Stevens-Johnson syndrome can be increased when Allopurinol is combined with Carbamazepine.]
[C09CA01, losartan, The metabolism of Carbamazepine can be decreased when combined with Losartan.]
[S01XA14, heparin, The risk or severity of bleeding can be increased when Heparin is combined with Carbamazepine.]
[B05CB03, magnesium citrate, Magnesium citrate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC03, magnesium gluconate, Magnesium gluconate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be increased when combined with Carbamazepine.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01XX03, altretamine, The risk or severity of adverse effects can be increased when Altretamine is combined with Carbamazepine.]
[N05CA16, hexobarbital, Carbamazepine may increase the Change in thyroid function activities of Hexobarbital.]
[J05AG01, nevirapine, The metabolism of Carbamazepine can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Carbamazepine can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The metabolism of Nimesulide can be increased when combined with Carbamazepine.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C02DB02, hydralazine, The metabolism of Carbamazepine can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Carbamazepine.]
[R05DA03, hydrocodone, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Carbamazepine can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Carbamazepine.]
[B05XA17, potassium acetate, Potassium acetate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01XA07, aluminum potassium sulfate, Potassium alum can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G04BD06, propiverine, The metabolism of Propiverine can be increased when combined with Carbamazepine.]
[P01BA02, hydroxychloroquine, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Prothipendyl.]
[B05AA07, hetastarch, Hydroxyethyl Starch may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G03DA03, 17-alpha-hydroxyprogesterone, The metabolism of Hydroxyprogesterone can be increased when combined with Carbamazepine.]
[L01XX05, hydroxyurea, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[J04AB04, rifabutin, The metabolism of Carbamazepine can be increased when combined with Rifabutin.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be increased when combined with Carbamazepine.]
[B05XA08, sodium acetate, Sodium acetate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B05CB02, sodium citrate, The risk or severity of bleeding can be increased when Sodium citrate is combined with Carbamazepine.]
[L01DB06, idarubicin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be increased when combined with Carbamazepine.]
[N01AH03, sufentanil, The metabolism of Sufentanil can be increased when combined with Carbamazepine.]
[N06AA02, imipramine, The metabolism of Imipramine can be increased when combined with Carbamazepine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be increased when combined with Carbamazepine.]
[R01AD07, tixocortol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Tixocortol.]
[M03BX02, tizanidine, Carbamazepine may increase the Change in thyroid function activities of Tizanidine.]
[L01CE01, topotecan, Carbamazepine may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[C03BA11, indapamide, The risk or severity of adverse effects can be increased when Indapamide is combined with Carbamazepine.]
[S01BC01, indomethacin, The risk or severity of adverse effects can be increased when Indomethacin is combined with Carbamazepine.]
[A16AX05, zinc acetate, Zinc acetate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CB02, zinc gluconate, Zinc gluconate can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A11HA07, inositol, Inositol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The risk or severity of adverse effects can be increased when Interferon alfa-2a is combined with Carbamazepine.]
[L03AB05, interferon alfa-2b, The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Carbamazepine.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be increased when combined with Carbamazepine.]
[A03AA30, piperidolate, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA25, eculizumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Eculizumab.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Articaine.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be increased when combined with Carbamazepine.]
[V08AB02, iohexol, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Iohexol.]
[N05BA12, alprazolam, The metabolism of Carbamazepine can be decreased when combined with Alprazolam.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be increased when combined with Carbamazepine.]
[R06AE01, buclizine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C10AA06, cerivastatin, The metabolism of Carbamazepine can be increased when combined with Cerivastatin.]
[L01XX35, anagrelide, The metabolism of Anagrelide can be increased when combined with Carbamazepine.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Alprenolol.]
[C03BA02, quinethazone, The risk or severity of adverse effects can be increased when Quinethazone is combined with Carbamazepine.]
[L03AB09, interferon alfacon-1, The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Carbamazepine.]
[V03AB01, ipecac, The metabolism of Ipecac can be increased when combined with Carbamazepine.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Iprindole.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Iproniazid.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be increased when combined with Carbamazepine.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Isocarboxazid.]
[P01AX06, atovaquone, The metabolism of Atovaquone can be increased when combined with Carbamazepine.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Isoflurane.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Carbamazepine.]
[J04AC01, isoniazid, The metabolism of Carbamazepine can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Inosine pranobex may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[D10BA01, isotretinoin, The metabolism of Isotretinoin can be increased when combined with Carbamazepine.]
[P02CF01, ivermectin, The metabolism of Ivermectin can be increased when combined with Carbamazepine.]
[B01AE06, bivalirudin, The risk or severity of bleeding can be increased when Bivalirudin is combined with Carbamazepine.]
[J01FA07, josamycin, The metabolism of Carbamazepine can be decreased when combined with Josamycin.]
[N06AX18, reboxetine, The metabolism of Reboxetine can be increased when combined with Carbamazepine.]
[S01AA24, kanamycin, Kanamycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A07BC02, kaolin, Kaolin can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC07, tocilizumab, The metabolism of Carbamazepine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be increased when combined with Carbamazepine.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ketanserin.]
[B01AC22, prasugrel, Prasugrel may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[H02CA04, levoketoconazole, The metabolism of Carbamazepine can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Carbamazepine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be increased when combined with Carbamazepine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V03AC03, deferasirox, The metabolism of Deferasirox can be increased when combined with Carbamazepine.]
[L04AA24, abatacept, The metabolism of Carbamazepine can be increased when combined with Abatacept.]
[D10AX04, aluminum oxide, Aluminum oxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04BC09, rotigotine, Carbamazepine may increase the sedative activities of Rotigotine.]
[J01MB02, nalidixic acid, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Nalidixic acid.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[D11AX02, gamma-linolenic acid, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Gamolenic acid.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AX09, maraviroc, The metabolism of Maraviroc can be increased when combined with Carbamazepine.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AX18, lacosamide, The serum concentration of Lacosamide can be decreased when it is combined with Carbamazepine.]
[C03CC01, ethacrynic acid, Etacrynic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R05CB06, ambroxol, The metabolism of Ambroxol can be increased when combined with Carbamazepine.]
[L01DC03, mitomycin, The risk or severity of adverse effects can be increased when Mitomycin is combined with Carbamazepine.]
[G03AD01, levonorgestrel, The serum concentration of Levonorgestrel can be decreased when it is combined with Carbamazepine.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Levodopa.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Lidocaine.]
[C08EX01, lidoflazine, The metabolism of Lidoflazine can be increased when combined with Carbamazepine.]
[S01AA21, amikacin, Amikacin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Carbamazepine can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be increased when combined with Carbamazepine.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The metabolism of Lisuride can be increased when combined with Carbamazepine.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Lofepramine.]
[L01AD02, lomustine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Lomustine.]
[A07DA03, loperamide, The metabolism of Loperamide can be increased when combined with Carbamazepine.]
[N05BA06, lorazepam, Carbamazepine may increase the Change in thyroid function activities of Lorazepam.]
[C10AA02, lovastatin, The metabolism of Carbamazepine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Loxapine.]
[J01AA04, lymecycline, The metabolism of Lymecycline can be increased when combined with Carbamazepine.]
[G03DC03, lynestrenol, The serum concentration of Lynestrenol can be decreased when it is combined with Carbamazepine.]
[L01EG01, temsirolimus, The metabolism of Carbamazepine can be decreased when combined with Temsirolimus.]
[B05XA11, magnesium chloride, Magnesium chloride can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC10, magnesium oxide, Magnesium oxide can cause a decrease in the absorption of Carbamazepine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Magnesium sulfate.]
[L01BA05, pralatrexate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pralatrexate.]
[L01EA03, nilotinib, The metabolism of Carbamazepine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be increased when combined with Carbamazepine.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mazindol.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01AA05, mechlorethamine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mechlorethamine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Meclizine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05BA03, medazepam, Carbamazepine may increase the Change in thyroid function activities of Medazepam.]
[G03DB03, medrogestone, The metabolism of Medrogestone can be increased when combined with Carbamazepine.]
[P01BC02, mefloquine, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Mefloquine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The risk or severity of bleeding can be increased when Nadroparin is combined with Carbamazepine.]
[B01AB05, enoxaparin, The risk or severity of bleeding can be increased when Enoxaparin is combined with Carbamazepine.]
[B01AB04, dalteparin, The risk or severity of bleeding can be increased when Dalteparin is combined with Carbamazepine.]
[N05CH01, melatonin, The metabolism of Melatonin can be increased when combined with Carbamazepine.]
[L01AA03, melphalan, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Melphalan.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02AB02, meperidine, The metabolism of Meperidine can be increased when combined with Carbamazepine.]
[C01CA11, mephentermine, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Mephentermine.]
[N03AB04, mephenytoin, Carbamazepine may increase the Change in thyroid function activities of Mephenytoin.]
[N03AA01, mephobarbital, Carbamazepine may increase the Change in thyroid function activities of Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Carbamazepine.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Meptazinol.]
[G04BX16, tiopronin, Tiopronin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L02BG01, aminoglutethimide, The metabolism of Carbamazepine can be increased when combined with Aminoglutethimide.]
[C03BC01, mersalyl, Mersalyl may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mesoridazine.]
[N05AX13, paliperidone, The metabolism of Carbamazepine can be decreased when combined with Paliperidone.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be increased when combined with Carbamazepine.]
[H01CB03, lanreotide, The metabolism of Carbamazepine can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Methadone can be increased when combined with Carbamazepine.]
[N06BA03, methamphetamine, Metamfetamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A03AB07, methantheline, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Methapyrilene.]
[N05CM01, methaqualone, The metabolism of Methaqualone can be increased when combined with Carbamazepine.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AA30, metharbital, Carbamazepine may increase the Change in thyroid function activities of Metharbital.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Carbamazepine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pemetrexed.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Carbamazepine.]
[N05CA15, methohexital, Carbamazepine may increase the Change in thyroid function activities of Methohexital.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Carbamazepine is combined with Ziconotide.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be increased when combined with Carbamazepine.]
[N05AA02, methotrimeprazine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Carbamazepine.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V04CG05, methylene blue, Carbamazepine may increase the serotonergic activities of Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Carbamazepine can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The serum concentration of Aminophylline can be decreased when it is combined with Carbamazepine.]
[N06BA04, methylphenidate, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Methylphenidate.]
[H02AB04, methylprednisolone, The metabolism of Carbamazepine can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The serum concentration of Rufinamide can be decreased when it is combined with Carbamazepine.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be increased when combined with Carbamazepine.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Methyprylon.]
[N02CA04, methysergide, The metabolism of Methysergide can be increased when combined with Carbamazepine.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Carbamazepine.]
[C03BA08, metolazone, The risk or severity of adverse effects can be increased when Metolazone is combined with Carbamazepine.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[P01AB01, metronidazole, The metabolism of Carbamazepine can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The serum concentration of Metyrapone can be decreased when it is combined with Carbamazepine.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be increased when combined with Carbamazepine.]
[N06AX03, mianserin, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Mianserin.]
[S02AA13, miconazole, The metabolism of Carbamazepine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be increased when combined with Carbamazepine.]
[B01AB07, parnaparin, The risk or severity of bleeding can be increased when Parnaparin is combined with Carbamazepine.]
[N05CD08, midazolam, The metabolism of Carbamazepine can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The serum concentration of Mifepristone can be decreased when it is combined with Carbamazepine.]
[B01AB10, tinzaparin, The risk or severity of bleeding can be increased when Tinzaparin is combined with Carbamazepine.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[D11AX01, minoxidil, The metabolism of Minoxidil can be increased when combined with Carbamazepine.]
[J01FA11, miocamycin, The metabolism of Carbamazepine can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Carbamazepine can be increased when combined with Mitotane.]
[L01DB07, mitoxantrone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mitoxantrone.]
[N06BA12, lisdexamfetamine, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Lisdexamfetamine.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Molindone.]
[L03AC01, aldesleukin, The metabolism of Carbamazepine can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Carbamazepine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Carbamazepine can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The metabolism of Morphine can be increased when combined with Carbamazepine.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be increased when combined with Carbamazepine.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Carbamazepine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be increased when combined with Carbamazepine.]
[G04BA01, ammonium chloride, Ammonium chloride may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L04AA52, ofatumumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ofatumumab.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Carbamazepine.]
[L04AA06, mycophenolic acid, The metabolism of Mycophenolic acid can be increased when combined with Carbamazepine.]
[M03AC03, vecuronium, The serum concentration of Vecuronium can be decreased when it is combined with Carbamazepine.]
[N05CA02, amobarbital, Carbamazepine may increase the Change in thyroid function activities of Amobarbital.]
[J05AJ01, raltegravir, The metabolism of Raltegravir can be increased when combined with Carbamazepine.]
[G04CA04, silodosin, The metabolism of Silodosin can be increased when combined with Carbamazepine.]
[R03BB01, ipratropium bromide, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
[G03XC01, raloxifene, The metabolism of Carbamazepine can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.]
[N03AB05, fosphenytoin, The serum concentration of Fosphenytoin can be decreased when it is combined with Carbamazepine.]
[L03AB08, interferon beta-1b, The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Carbamazepine.]
[C07AA12, nadolol, Nadolol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N04BC04, ropinirole, The metabolism of Ropinirole can be increased when combined with Carbamazepine.]
[J01CF06, nafcillin, The metabolism of Carbamazepine can be increased when combined with Nafcillin.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Carbamazepine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The metabolism of Naltrexone can be increased when combined with Carbamazepine.]
[L04AC03, anakinra, The metabolism of Carbamazepine can be increased when combined with Anakinra.]
[S01XA11, nandrolone, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Nandrolone phenpropionate.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M02AA12, naproxen, The metabolism of Naproxen can be increased when combined with Carbamazepine.]
[A10BG01, troglitazone, The metabolism of Carbamazepine can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be increased when combined with Carbamazepine.]
[L02BG04, letrozole, The metabolism of Letrozole can be increased when combined with Carbamazepine.]
[S03AA01, neomycin, Neomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Remifentanil.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be increased when combined with Carbamazepine.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AX14, iloperidone, The metabolism of Carbamazepine can be decreased when combined with Iloperidone.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L03AX16, plerixafor, Plerixafor may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01AA23, netilmicin, Netilmicin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Carbamazepine can be decreased when combined with Desvenlafaxine.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M04AA03, febuxostat, The metabolism of Febuxostat can be increased when combined with Carbamazepine.]
[H05BX02, paricalcitol, The metabolism of Paricalcitol can be increased when combined with Carbamazepine.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01XX01, amsacrine, The risk or severity of adverse effects can be increased when Amsacrine is combined with Carbamazepine.]
[C10AD02, niacin, The metabolism of Carbamazepine can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nialamide.]
[C08CA04, nicardipine, The metabolism of Carbamazepine can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, The metabolism of Carbamazepine can be decreased when combined with Nifedipine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C08CA06, nimodipine, The metabolism of Nimodipine can be increased when combined with Carbamazepine.]
[C08CA07, nisoldipine, The metabolism of Carbamazepine can be decreased when combined with Nisoldipine.]
[N05CD02, nitrazepam, Carbamazepine may increase the Change in thyroid function activities of Nitrazepam.]
[C08CA08, nitrendipine, The metabolism of Carbamazepine can be decreased when combined with Nitrendipine.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05CF03, zaleplon, Carbamazepine may increase the Change in thyroid function activities of Zaleplon.]
[N04BC05, pramipexole, Carbamazepine may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Nomifensine.]
[G03DC02, norethindrone, The serum concentration of Norethisterone can be decreased when it is combined with Carbamazepine.]
[G03AC07, norgestrienone, The serum concentration of Norgestrienone can be decreased when it is combined with Carbamazepine.]
[C02KX01, bosentan, The metabolism of Carbamazepine can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be increased when combined with Carbamazepine.]
[R05DA07, noscapine, The metabolism of Carbamazepine can be decreased when combined with Noscapine.]
[B01AC16, eptifibatide, The risk or severity of bleeding can be increased when Eptifibatide is combined with Carbamazepine.]
[G02CA02, nylidrin, The metabolism of Nylidrin can be increased when combined with Carbamazepine.]
[B01AB08, reviparin, The risk or severity of bleeding can be increased when Reviparin is combined with Carbamazepine.]
[H01CB02, octreotide, The serum concentration of Carbamazepine can be increased when it is combined with Octreotide.]
[J01FA05, oleandomycin, The metabolism of Carbamazepine can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Carbamazepine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Carbamazepine can be increased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Opipramol.]
[N02AA02, opium, The metabolism of Opium can be increased when combined with Carbamazepine.]
[B01AD07, reteplase, The risk or severity of bleeding can be increased when Reteplase is combined with Carbamazepine.]
[B01AD09, ancrod, The risk or severity of bleeding can be increased when Ancrod is combined with Carbamazepine.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be increased when combined with Carbamazepine.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A14AA08, oxandrolone, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Oxandrolone.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Carbamazepine can be decreased when combined with Oxycodone.]
[A14AA05, oxymetholone, The therapeutic efficacy of Carbamazepine can be increased when used in combination with Oxymetholone.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be increased when combined with Carbamazepine.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Oxypertine.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A03AB03, oxyphenonium, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The metabolism of Asenapine can be increased when combined with Carbamazepine.]
[B01AB09, danaparoid, The risk or severity of bleeding can be increased when Danaparoid is combined with Carbamazepine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine.]
[M03AC01, pancuronium, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[J04AB30, capreomycin, Capreomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G03DB06, chlormadinone, The serum concentration of Chlormadinone can be decreased when it is combined with Carbamazepine.]
[N05CC05, paraldehyde, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The metabolism of Carbamazepine can be increased when combined with Paramethasone.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pargyline.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be increased when combined with Carbamazepine.]
[C07AA23, penbutolol, Penbutolol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AG03, penfluridol, The metabolism of Penfluridol can be increased when combined with Carbamazepine.]
[M01CC01, penicillamine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Penicillamine.]
[J01CE09, penicillin G procaine, Procaine benzylpenicillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J07AF01, diphtheria toxoid vaccine, inactivated, The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Carbamazepine.]
[J07AM01, tetanus toxoid vaccine, inactivated, The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Carbamazepine.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pentazocine.]
[N05CA01, pentobarbital, Carbamazepine may increase the Change in thyroid function activities of Pentobarbital.]
[L01XX08, pentostatin, The risk or severity of adverse effects can be increased when Pentostatin is combined with Carbamazepine.]
[C04AD03, pentoxifylline, The serum concentration of Pentoxifylline can be decreased when it is combined with Carbamazepine.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Pergolide.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be increased when combined with Carbamazepine.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be increased when combined with Carbamazepine.]
[J07AJ, pertussis vaccine, The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Carbamazepine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be increased when combined with Carbamazepine.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Phenazocine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N06AF03, phenelzine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Phenelzine.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Phenindione is combined with Carbamazepine.]
[N03AA02, phenobarbital, Carbamazepine may increase the Change in thyroid function activities of Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Phenoperidine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be increased when combined with Carbamazepine.]
[A08AA01, phentermine, The metabolism of Phentermine can be increased when combined with Carbamazepine.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M02AA01, phenylbutazone, The metabolism of Carbamazepine can be increased when combined with Phenylbutazone.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be increased when combined with Carbamazepine.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Phenytoin can be decreased when it is combined with Carbamazepine.]
[L04AB06, golimumab, The metabolism of Carbamazepine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be increased when combined with Carbamazepine.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C08CX01, mibefradil, The metabolism of Carbamazepine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Carbamazepine.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C10AA05, atorvastatin, The metabolism of Carbamazepine can be decreased when combined with Atorvastatin.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AE01, saquinavir, The serum concentration of Saquinavir can be decreased when it is combined with Carbamazepine.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be increased when combined with Carbamazepine.]
[N06BX03, piracetam, Piracetam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A02BX03, pirenzepine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Piritramide.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be increased when combined with Carbamazepine.]
[N02CX01, pizotyline, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Carbamazepine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Carbamazepine can be decreased when combined with Irbesartan.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Proxibarbal.]
[B01AC13, abciximab, The risk or severity of bleeding can be increased when Abciximab is combined with Carbamazepine.]
[S01XA13, alteplase, The risk or severity of bleeding can be increased when Alteplase is combined with Carbamazepine.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be increased when combined with Carbamazepine.]
[A03AE01, alosetron, The metabolism of Alosetron can be increased when combined with Carbamazepine.]
[L04AC08, canakinumab, The metabolism of Carbamazepine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The risk or severity of adverse effects can be increased when Polythiazide is combined with Carbamazepine.]
[J05AE03, ritonavir, The serum concentration of Ritonavir can be decreased when it is combined with Carbamazepine.]
[A10BH03, saxagliptin, The metabolism of Carbamazepine can be decreased when combined with Saxagliptin.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05BA11, prazepam, The metabolism of Prazepam can be increased when combined with Carbamazepine.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be increased when combined with Carbamazepine.]
[S03BA02, prednisolone, The metabolism of Carbamazepine can be increased when combined with Prednisolone.]
[H02AB07, prednisone, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Prednisone.]
[C01DX02, prenylamine, The metabolism of Prenylamine can be increased when combined with Carbamazepine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Carbamazepine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Carbamazepine can be decreased when combined with Primaquine.]
[N03AA03, primidone, Carbamazepine may increase the Change in thyroid function activities of Primidone.]
[M04AB01, probenecid, The metabolism of Carbamazepine can be increased when combined with Probenecid.]
[C01BA02, procainamide, Carbamazepine may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[S01HA05, procaine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Procarbazine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be increased when combined with Carbamazepine.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be increased when combined with Carbamazepine.]
[N04AA04, procyclidine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The serum concentration of Progesterone can be decreased when it is combined with Carbamazepine.]
[N05AA03, promazine, The metabolism of Promazine can be increased when combined with Carbamazepine.]
[G03DB07, promegestone, The metabolism of Promegestone can be increased when combined with Carbamazepine.]
[R06AD02, promethazine, Promethazine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[C01BC03, propafenone, The metabolism of Propafenone can be increased when combined with Carbamazepine.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Propanidid.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Periciazine.]
[N05CM06, propiomazine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be increased when combined with Carbamazepine.]
[N01AX10, propofol, The metabolism of Carbamazepine can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Carbamazepine can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The serum concentration of Propranolol can be decreased when it is combined with Carbamazepine.]
[H03BA02, propylthiouracil, The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Carbamazepine.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[B01AC09, epoprostenol, Epoprostenol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[R03DC03, montelukast, The metabolism of Montelukast can be increased when combined with Carbamazepine.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Protriptyline is combined with Carbamazepine.]
[R01BA02, pseudoephedrine, The risk or severity of serotonin syndrome can be increased when Carbamazepine is combined with Pseudoephedrine.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be increased when combined with Carbamazepine.]
[N07XX07, dalfampridine, Dalfampridine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A03AB15, diphemanil, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Carbamazepine.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Styramate.]
[P02CC01, pyrantel, Pyrantel may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J06BB05, rabies immune globulin, human, The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Carbamazepine.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Mepyramine.]
[P01AX05, quinacrine, The metabolism of Carbamazepine can be decreased when combined with Quinacrine.]
[C01BA01, quinidine, The metabolism of Quinidine can be increased when combined with Carbamazepine.]
[P01BC01, quinine, The metabolism of Carbamazepine can be increased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be increased when combined with Carbamazepine.]
[C02AA02, reserpine, The metabolism of Carbamazepine can be increased when combined with Reserpine.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Carbamazepine can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Oxitriptan.]
[J01FA06, roxithromycin, The metabolism of Carbamazepine can be decreased when combined with Roxithromycin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Sulfasalazine.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[S01FA02, scopolamine, The metabolism of Scopolamine can be increased when combined with Carbamazepine.]
[N05CA06, secobarbital, Carbamazepine may increase the Change in thyroid function activities of Secobarbital.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Selegiline.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Carbamazepine is combined with Obinutuzumab.]
[J01GB08, sisomicin, Sisomicin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[A12CD01, sodium fluoride, Sodium fluoride may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[M05BX04, denosumab, The risk or severity of adverse effects can be increased when Denosumab is combined with Carbamazepine.]
[H01CB01, somatostatin, The metabolism of Carbamazepine can be decreased when combined with Somatostatin.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be increased when combined with Carbamazepine.]
[L03AX17, sipuleucel-T, The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Carbamazepine.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be increased when combined with Carbamazepine.]
[V09AB03, ioflupane I-123, Ioflupane I-123 may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Technetium Tc-99m exametazime may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Florbetaben (18F) may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[N03AG01, valproic acid, The serum concentration of carbamazepine-10,11 epoxide (CBZ-E), an active metabolite of Carbamazepine, can be increased when used in combination with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Carbamazepine can be increased when combined with Hydrocortisone butyrate.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[J05AE02, indinavir, Strong CYP3A4 inducers - protease inhibitors]
[J05AE04, nelfinavir, Strong CYP3A4 inducers - protease inhibitors]
[J05AE09, tipranavir, Strong CYP3A4 inducers - protease inhibitors]
[J05AE05, amprenavir, Strong CYP3A4 inducers - protease inhibitors]
[J05AE08, atazanavir, Strong CYP3A4 inducers - protease inhibitors]
[J05AE07, fosamprenavir, Strong CYP3A4 inducers - protease inhibitors]
[J05AE10, darunavir, Strong CYP3A4 inducers - protease inhibitors]
[J05AE01, saquinavir, Strong CYP3A4 inducers - protease inhibitors]
[J05AE03, ritonavir, Strong CYP3A4 inducers - protease inhibitors]
